127588-56-1

Basic information

• Product Name: 4-(3-thioxo-3H-1,2-dithiol-4-yl)benzoic acid
• Synonyms: 4-(3-thioxo-3H-1,2-dithiol-4-yl)benzoic acid
• CAS NO: 127588-56-1
• Molecular Weight: 254.354
• Mol File: 127588-56-1.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 4-(3-thioxo-3H-1,2-dithiol-4-yl)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-thioxo-3H-1,2-dithiol-4-yl)benzoic acid(127588-56-1)
• EPA Substance Registry System: 4-(3-thioxo-3H-1,2-dithiol-4-yl)benzoic acid(127588-56-1)

Safety Data

• Hazardous Substances Data: 127588-56-1(Hazardous Substances Data)

Upstream product

• 127588-58-3 C₁₂H₁₀O₂S₃ 
• 19024-50-1 ethyl 4-isopropylbenzoate 
• 536-66-3 p-isopropylbenzoic acid 
• 127588-57-2 methyl 4-(3-thioxo-3H-1,2-dithiol-4-yl)benzoate 

Downstream Products

• 1070174-97-8 4-(3-thioxo-3H-1,2-dithiol-4-yl)benzoic acid 2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5-ylphenyl)-benzyl]imidazole-5-methyl ester 
• 2387-23-7 1,3-Dicyclohexylurea 
• 1235581-86-8 methyl 3-(3,4-dihydroxyphenyl)-2-(4-(3-thioxo-3H-1,2-dithiol-4-yl)benzamido)propanoate 
• 1215295-18-3 1-(tert-butylamino)-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-2-yl 4-(3-thioxo-3H-1,2-dithiol-4-yl)benzoate 
• 1215295-15-0 2-(9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecyhydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl 4-(3-thioxo-3H-1,2-dithiol-4-yl)benzoate 
• 1155413-90-3 N¹-phenyl-N⁸-(4-(3-thioxo-3H-1,2-dithiol-4-yl)benzoyloxy)octanediamide 
• 1134191-23-3 ester of (6R,12aR)-2,3,6,7,12,12a-hexahydro-2-hydroxy-6-(3,4-methylendioxyphenyl)-pyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione with 4-(3-thioxo-3H-1,2-dithiol-4-yl)benzoic acid 

Relevant articles and documents

New aryldithiolethione derivatives as potent histone deacetylase inhibitors

A series of dithiolethione derivatives was synthesized and the in vitro HDAC inhibitory activity was tested. The most active compounds, 1 and 2, exhibited an IC50 in nM range with a strong hyperacetylation of histone H4 in A549 cells. The HDAC

OCULAR PHARMACEUTICAL COMPOSITIONS

The present invention relates to novel derivatives of opthalmic compounds for the treatment of ocular diseases.

Cardiovascular agents

The present invention relates to novel compounds that are derivatives of angiotensin receptor blocker (ARB) that comprise in their formula a polysulfurated group and that are useful for treating cardio-vascular diseases, such as hypertension, ischemic heart disease, atherosclerosis, metabolic syndrome, etc. also in combination with other cardiovascular agents.